Long-term Survival After Radiofrequency Ablation for Liver Cancer
Author Information
Author(s): Thanos Loukas, Ptohis Nikolaos, Pomoni Anastasia, Sotiropoulou Evangelia, Pomoni Maria, Kelekis Dimitrios
Primary Institution: Department of Computed Tomography and Interventional Radiology, “Sotiria” General Hospital of Chest Diseases
Hypothesis
Can radiofrequency ablation (RFA) provide long-term survival benefits for patients with hepatocellular carcinoma (HCC)?
Conclusion
The patient treated with RFA for HCC survived more than 12 years and maintained excellent clinical status.
Supporting Evidence
- The patient had a single lesion and was initially a suitable candidate for surgical resection.
- RFA was performed three times over 12 years due to tumor progression and recurrence.
- Post-treatment, the patient's AFP levels normalized and remained stable for years.
Takeaway
A 72-year-old man with liver cancer was treated with a special heat technique called radiofrequency ablation, and he lived for over 12 years after the treatment.
Methodology
The patient underwent radiofrequency ablation (RFA) under local anesthesia, with follow-up imaging to assess treatment response.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
One 72-year-old male patient with cirrhosis related to hepatitis C.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website